Giovanni Pellacani Google Scholar: h-index, Total Citations, and Citation Map
Giovanni Pellacani's h-index is 89 (605 i10-index, 36,794+ total citations across 1,000+ publications) according to Google Scholar as of October 2026. Giovanni Pellacani is affiliated with La Sapienza, University of Rome.
Giovanni Pellacani is a researcher affiliated with La Sapienza, University of Rome, specializing in dermatology, dermoscopy, confocal microsocpy. Their work has been cited 36,794 times. This profile visualizes their global influence, spanning a global audience.
Giovanni Pellacani's Citation Metrics
Bibliometric impact based on 1,000 indexed publications. Of these, 19 are original research articles — the rest are literature highlights, conference abstracts or theses.
- H-Index
- 89
- i10-Index
- 605
- Total Citations
- 36,794
- Citing Countries
- 0
As of October 2026.
Giovanni Pellacani has an h-index of 89 and 36,794 total citations across 1000 publications, with research cited by institutions in 0 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Giovanni Pellacani's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Showing partial map from open academic databases
Upgrade ($39.98) for the complete Google Scholar crawl.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Two phase 3 trials of dupilumab versus placebo in atopic dermatitis
20162,497
Top Citing Countries
Top Citing Institutions
No institution data available.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Giovanni Pellacani's research
Giovanni Pellacani is a researcher in dermatology, dermoscopy and confocal microsocpy at La Sapienza, University of Rome. Their work has been cited 36,794 times across 1,000 publications (h-index 89), according to Google Scholar.
Their most-cited work, “Two phase 3 trials of dupilumab versus placebo in atopic dermatitis” (2016), has accumulated 2,497 citations. Other influential works include “European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment–update 2019” (2020) with 793 citations and “The impact of in vivo reflectance confocal microscopy for the diagnostic accuracy of melanoma and equivocal melanocytic lesions” (2007) with 563 citations.
